Related Experiment Videos
Percutaneous transhepatic cholecysto-lithotripsy (PTCL)
H Wenk1, S Thomas, N Schmeller
1Klinik für Chirurgie, Medizinische Universität zu Lübeck.
Endoscopy
|September 1, 1989
Summary
Percutaneous transhepatic cholecystolithotripsy (PTCL) offers a minimally invasive treatment for gallstones. This single-session procedure using laser or ultrasound has shown no severe side effects in clinical use.
Area of Science:
- Minimally Invasive Surgery
- Gastroenterology
- Medical Device Technology
Background:
- Gallstones (cholelithiasis) are a common condition requiring treatment.
- Traditional gallstone treatments can involve significant invasiveness and recovery times.
- Minimally invasive techniques are increasingly preferred for improved patient outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous transhepatic cholecystolithotripsy (PTCL) for gallstone treatment.
- To assess the feasibility of performing all PTCL steps within a single session.
- To document observed side effects during clinical application of PTCL.
Main Methods:
- Percutaneous transhepatic cholecystolithotripsy (PTCL) procedure.
- Utilized laser or ultrasound energy for stone fragmentation.
- All procedural steps conducted in one operative session.
Main Results:
- Successful gallstone fragmentation and removal via PTCL.
- Procedure completed effectively within a single session.
- No severe adverse events were reported during clinical use.
Conclusions:
- Percutaneous transhepatic cholecystolithotripsy (PTCL) is a viable, minimally invasive option for gallstone treatment.
- The single-session nature of PTCL enhances procedural efficiency.
- PTCL demonstrates a favorable safety profile with no severe side effects observed clinically.